SCHEMBL7073987

SCHEMBL7073987

CC1=C(C)C(=O)SC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10073565 0.77
SCHEMBL16200839 0.65
SCHEMBL18428240 0.65
SCHEMBL138955 0.58
SCHEMBL22654547 0.58 ALOX15 (0.37)
Duroquinone SCHEMBL58325 0.58 MAOA (0.38)
Duroquinone SCHEMBL11473070 0.55 MAOA (0.36)
SCHEMBL10486657 0.55 MAOA (0.36)
SCHEMBL13581861 0.55 MAOA (0.36)
SCHEMBL2178472 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200031796-A1 COMPOSITION COMPRISING A COMPOUND OF THIOLACTONE TYPE AND A PARTICULAR SOLVENT AND PROCESS FOR TREATING KERATIN MATERIALS WITH THE COMPOSITION L'OREAL (FR) 2020-01-30 US disclosed
WO-2003059071-A1 ANTIVIRAL COMPOSITION DERIVED FROM ALLIUM CEPA AND THERAPEUTIC USE THEREOF DIEPON S.A. (UY) 2003-07-24 WO disclosed
US-20030026859-A1 Antiviral composition derived from Allium cepa and therapeutic use thereof DIEPON S.A. (UY) 2003-02-06 US disclosed
US-6340483-B1 ORALLY ADMINISTERING AMOUNT OF DEHYDRATED PARTICULATE ALLIUM CEPA PLANT MATERIAL THAT IS PROCESSED TO PROVIDE PARTICLES FOR THERAPY OF ACQUIRED IMMUNE DEFICIENCY SYNDROME(AIDS) DIEPON, S.A. (UY) 2002-01-22 US disclosed